|
|
|
|
|
|
|
22/10/02 |
|
|
GPs wake up to importance of sleep |
|
|
|
|
 |
|
|
|
|
|
|
|
22nd October 2002 - The first Primary Care Sleep Group, uniting GPs with an interest in sleep medicine, is announced today. |
|
 |
|
|
|
|
|
|
 |
|
|
|
 |
|
|
|
|
|
|
 |
|
|
|
|
281KB |
|
|
|
|
|
|
|
 |
|
|
 |
|
|
|
|
|
|
|
15/10/02 |
|
|
Time to Challenge Inadequate Anaemia Treatment for Cancer Patients |
|
|
|
|
|
|
|
|
|
|
|
|
October 2002 - A consensus statement launched at this week’s European Society for Medical Oncology Congress (ESMO) in Nice is set to challenge current UK treatment options for cancer-related anaemia. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
167KB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23/09/02 |
|
|
Boots Launches World's First Digital Disposable Hearing Aid - Hear More, See Less |
|
|
|
|
|
|
|
|
|
|
|
|
Boots launched the world's first digital disposable hearing aid, Songbird DigitalTM, today. The revolutionary device, which is available in Boots Hearingcare centres nationwide, brings affordable digital hearing aid technology to the high street.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
180KB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03/09/02 |
|
|
Early Combination Of Carvedilol and ACE Inhibition Prevents Progression of Heart Failure |
|
|
|
|
|
|
|
|
|
|
|
|
The clinical outcome of patients with mild chronic heart failure can be significantly improved by the early initiation of carvedilol (Dilatrend®), in combination with the ACE inhibitor enalapril, according to new study results presented at the European Society of Cardiology (ESC) Congress today. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40KB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28/06/02 |
|
|
Switch to US-sourced plasma further strengthens safety track record of OCTAPLAS® |
|
|
|
|
|
|
|
|
|
|
|
|
Coventry, UK, 28 June 2002 - Octapharma Limited has today announced it has written to haematologists and other specialists involved with the provision of blood products in the National Health Service (NHS) indicating a switch to United States (US) plasma in the manufacture of Octaplas supplied to the United Kingdom (UK).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
128KB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25/06/02 |
|
|
Leading the way in Heart Failure MPs learn about impact of heart failure in the UK |
|
|
|
|
|
|
|
|
|
|
|
|
Members of Parliament heard today that the vast majority (up to 90%) of patients with heart failure are not receiving beta-blocker therapy for their condition despite the guidance issued in the National Service Framework for Coronary Heart Disease two years ago. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28KB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24/04/02 |
|
|
World’s Largest Independent Healthcare PR Organisation Launched Today |
|
|
|
|
|
|
|
|
|
|
|
|
GLOBALHealthPR, the world’s largest independent organisation of specialist healthcare public relations consultants, was launched today. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39KB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17/04/02 |
|
|
Santé Communications wins new business hat-trick |
|
|
|
|
|
|
|
|
|
|
|
|
Santé Communications today announced winning three multi-agency pitches in six weeks worth over £400,000. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11Kb |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20/02/02 |
|
|
The HEART Solution |
|
|
|
|
|
|
|
|
|
|
|
|
A new initiative which will help optimise the identification, diagnosis, treatment and after-care of patients with heart failure
Welwyn Garden City, UK, 20 February 2002 - Roche UK is pleased to announce the launch of the first integrated healthcare solution for tackling heart failure, The HEART Solution (HEart FAiluRe ManagemenT Solution). The HEART Solution gives health professionals such as nurses, GPs and hospital doctors an opportunity to work together to improve outcomes for patients and to help them meet the National Service Framework (NSF) targets for coronary heart disease.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
118Kb |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
